Private Equity Profile
In the last 3 years, Montreux Equity Partners has acquired 1 company.
Montreux Equity Partners’ most common sectors for investment are medical products (44%) and life science (32%). The Firm’s most common investment types include venture (72%) and buyout (lbo, mbo, mbi) (12%). In total, Montreux Equity Partners has invested in 4 US states and 4 different countries. Its largest (disclosed) acquisition occurred in 2006 when it acquired OREXIGEN Therapeutics for $30M.
In the last 3 years, Montreux Equity Partners has exited 1 company. The Firm’s most common exit type is trade sale (61%). Montreux Equity Partners’ largest (disclosed) exit occurred in 2007 when it sold Cerexa for $480M.
Join Mergr to view Montreux Equity Partners’ full profile and discover more small private equity firms just like it.
M&A Total Activity48
- M&A Buy Activity25
- M&A Sell Activity23
- Total Sectors Invested 7
- Total Countries Invested 4
- M&A Buy/Sell Connections 25
- M&A Advisors 1